News and Announcements
Leaf Resources enters Collaboration Agreement with ZeaChem Inc
- Published October 23, 2014 11:07AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
ASX Announcement; 16 October 2014
The Directors of Leaf Resources are pleased to announce the signing of a Collaboration Agreements with ZeaCheam Inc. of Lakewood, Colarado. The agreement covers the evaluation of ZeaCheam and Leaf Resources of the Leaf Glycell process for the production of fermentable sugars at ZeaChem’s demonstration plant at Boardman, Oregon. The trials will usePoplar as a feedstock.
Zen Richards, CEO of Leaf Resources, said: “ZeaChem has been a leader in the cellulosic field for many years and has multiple patents in the field including for the production of acetic acid from cellulosic sugars. ZeaChem’s Boardman plant utilizes Andritz equipment and is very similar in configuration to the Andritz trial facility at Springfield, Ohio where Leaf Resources has been running development trials for almost one year.”
To read full announcement please, click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
